ID

31761

Beskrivning

Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG; ODM derived from: https://clinicaltrials.gov/show/NCT00899847

Länk

https://clinicaltrials.gov/show/NCT00899847

Nyckelord

Versioner (1)
  1. 2018-09-26 2018-09-26 -
Rättsinnehavare

Wen-Kai Weng, Stanford University

Uppladdad den

26 september 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Transplantation, Homologous, multiple myeloma and plasma cell leukemia NCT00899847

Engelsk

Eligibility Transplantation, Homologous, multiple myeloma and plasma cell leukemia NCT00899847

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
stage ii-iii multiple myeloma or have progression after initial treatment of stage i disease (durie salmon staging). patients with plasma cell leukemia are also included. pathology reviewed and the diagnosis confirmed at stanford university medical center.
Beskrivning

Multiple myeloma (stage ii-iii )/ progressed, plasma cell leukemia; pathology report

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C4528204
UMLS CUI [2,1]
C0026764
UMLS CUI [2,2]
C0242656
UMLS CUI [2,3]
C0231290
UMLS CUI [2,4]
C0087111
UMLS CUI [3]
C0023484
UMLS CUI [4]
C0807321
age > 18 years and <= 75 years.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
karnofsky performance status > 70%.
Beskrivning

Karnofsky performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C0206065
corrected dlco > 60%
Beskrivning

Carbon monoxide diffusing capacity

Datatyp

boolean

Alias
UMLS CUI [1]
C1516251
left ventricle ejection fraction (lvef) > 50%.
Beskrivning

Left ventricle ejection fraction

Datatyp

boolean

Alias
UMLS CUI [1]
C0428772
alt and ast must be <= 2x normal. total bilirubin <= 2 mg/dl unless hemolysis or gilbert's disease.
Beskrivning

ALT, AST, total bilirubin (except hemolysis and gilbert's disease)

Datatyp

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201913
UMLS CUI [4,1]
C0332300
UMLS CUI [4,2]
C0019054
UMLS CUI [5,1]
C0332300
UMLS CUI [5,2]
C0017551
estimated creatinine clearance > 50 ml/min.
Beskrivning

Creatinine clearance

Datatyp

boolean

Alias
UMLS CUI [1]
C0373595
have a related or unrelated hla-identical donor or one antigen/allele mismatched in hla-a, b, c or drb1.
Beskrivning

Hla-identical donor/one antigen/allele mismatched in hla-a, b, c or drb1

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0019721
UMLS CUI [1,2]
C0205280
UMLS CUI [1,3]
C0013018
UMLS CUI [2,1]
C0019728
UMLS CUI [2,2]
C1881865
UMLS CUI [3,1]
C0019737
UMLS CUI [3,2]
C1881865
UMLS CUI [4,1]
C0019751
UMLS CUI [4,2]
C1881865
UMLS CUI [5,1]
C0122040
UMLS CUI [5,2]
C1881865
signed informed consent.
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Inclusion criteria for donor
Beskrivning

Inclusion criteria for donor

Alias
UMLS CUI-1
C1512693
UMLS CUI-2
C0013018
age >=17.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
hiv seronegative
Beskrivning

HIV seronegative

Datatyp

boolean

Alias
UMLS CUI [1]
C0019698
donor must be capable of giving signed, informed consent
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
no contraindication to the administration of g-csf
Beskrivning

No contraindication filgrastim

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1298908
UMLS CUI [1,2]
C0522473
UMLS CUI [1,3]
C0210630
willing to have a central venous catheter placed for apheresis if peripheral veins are inadequate.
Beskrivning

Willing to have a central venous catheter

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0600109
UMLS CUI [1,2]
C1145640
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior allogeneic hematopoietic cell transplantation.
Beskrivning

Prior allogeneic hematopoietic cell transplantation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1705576
UMLS CUI [1,2]
C0332152
uncontrolled active infection.
Beskrivning

Uncontrolled active infection

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
uncontrolled congestive heart failure or angina.
Beskrivning

Uncontrolled congestive heart failure/angina

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0002962
pregnancy or nursing patients will be excluded from the study.
Beskrivning

Pregnancy/breast feeding patients

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
those who are hiv-positive will be excluded from the study due to high risk of lethal infection after hematopoietic cell transplantation.
Beskrivning

Hiv positive

Datatyp

boolean

Alias
UMLS CUI [1]
C0019699
donor evaluation exclusion criteria
Beskrivning

donor evaluation exclusion criteria

Alias
UMLS CUI-1
C0680251
UMLS CUI-2
C0013018
serious medical or psychological illness.
Beskrivning

Serious medical/psychological illness

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0205082
UMLS CUI [1,2]
C0262926
UMLS CUI [2]
C0004936
pregnant or lactating women are not eligible
Beskrivning

Pregnancy, lactating

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
prior malignancies within the last 5 years except for non-melanoma skin cancers
Beskrivning

Prior malignancies (except for non-melanoma skin cancers)

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0332300
UMLS CUI [1,4]
C0677898
UMLS CUI [1,5]
C0699893
Tillbaka till toppen

Similar models

Eligibility Transplantation, Homologous, multiple myeloma and plasma cell leukemia NCT00899847

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Multiple myeloma (stage ii-iii )/ progressed, plasma cell leukemia; pathology report
Item
stage ii-iii multiple myeloma or have progression after initial treatment of stage i disease (durie salmon staging). patients with plasma cell leukemia are also included. pathology reviewed and the diagnosis confirmed at stanford university medical center.
boolean
C0026764 (UMLS CUI [1,1])
C4528204 (UMLS CUI [1,2])
C0026764 (UMLS CUI [2,1])
C0242656 (UMLS CUI [2,2])
C0231290 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
C0023484 (UMLS CUI [3])
C0807321 (UMLS CUI [4])
Age
Item
age > 18 years and <= 75 years.
boolean
C0001779 (UMLS CUI [1])
Karnofsky performance status
Item
karnofsky performance status > 70%.
boolean
C0206065 (UMLS CUI [1])
Carbon monoxide diffusing capacity
Item
corrected dlco > 60%
boolean
C1516251 (UMLS CUI [1])
Left ventricle ejection fraction
Item
left ventricle ejection fraction (lvef) > 50%.
boolean
C0428772 (UMLS CUI [1])
ALT, AST, total bilirubin (except hemolysis and gilbert's disease)
Item
alt and ast must be <= 2x normal. total bilirubin <= 2 mg/dl unless hemolysis or gilbert's disease.
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201913 (UMLS CUI [3])
C0332300 (UMLS CUI [4,1])
C0019054 (UMLS CUI [4,2])
C0332300 (UMLS CUI [5,1])
C0017551 (UMLS CUI [5,2])
Creatinine clearance
Item
estimated creatinine clearance > 50 ml/min.
boolean
C0373595 (UMLS CUI [1])
Hla-identical donor/one antigen/allele mismatched in hla-a, b, c or drb1
Item
have a related or unrelated hla-identical donor or one antigen/allele mismatched in hla-a, b, c or drb1.
boolean
C0019721 (UMLS CUI [1,1])
C0205280 (UMLS CUI [1,2])
C0013018 (UMLS CUI [1,3])
C0019728 (UMLS CUI [2,1])
C1881865 (UMLS CUI [2,2])
C0019737 (UMLS CUI [3,1])
C1881865 (UMLS CUI [3,2])
C0019751 (UMLS CUI [4,1])
C1881865 (UMLS CUI [4,2])
C0122040 (UMLS CUI [5,1])
C1881865 (UMLS CUI [5,2])
Informed consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
Inclusion criteria for donor
C1512693 (UMLS CUI-1)
C0013018 (UMLS CUI-2)
Age
Item
age >=17.
boolean
C0001779 (UMLS CUI [1])
HIV seronegative
Item
hiv seronegative
boolean
C0019698 (UMLS CUI [1])
Informed consent
Item
donor must be capable of giving signed, informed consent
boolean
C0021430 (UMLS CUI [1])
No contraindication filgrastim
Item
no contraindication to the administration of g-csf
boolean
C1298908 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0210630 (UMLS CUI [1,3])
Willing to have a central venous catheter
Item
willing to have a central venous catheter placed for apheresis if peripheral veins are inadequate.
boolean
C0600109 (UMLS CUI [1,1])
C1145640 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Prior allogeneic hematopoietic cell transplantation
Item
prior allogeneic hematopoietic cell transplantation.
boolean
C1705576 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
Uncontrolled active infection
Item
uncontrolled active infection.
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Uncontrolled congestive heart failure/angina
Item
uncontrolled congestive heart failure or angina.
boolean
C0018802 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0002962 (UMLS CUI [2])
Pregnancy/breast feeding patients
Item
pregnancy or nursing patients will be excluded from the study.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
Hiv positive
Item
those who are hiv-positive will be excluded from the study due to high risk of lethal infection after hematopoietic cell transplantation.
boolean
C0019699 (UMLS CUI [1])
Item Group
donor evaluation exclusion criteria
C0680251 (UMLS CUI-1)
C0013018 (UMLS CUI-2)
Serious medical/psychological illness
Item
serious medical or psychological illness.
boolean
C0205082 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0004936 (UMLS CUI [2])
Pregnancy, lactating
Item
pregnant or lactating women are not eligible
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
Prior malignancies (except for non-melanoma skin cancers)
Item
prior malignancies within the last 5 years except for non-melanoma skin cancers
boolean
C0006826 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0332300 (UMLS CUI [1,3])
C0677898 (UMLS CUI [1,4])
C0699893 (UMLS CUI [1,5])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial